Tanimoto Sarina

CIK 00019512911 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001951291

Recent Transactions

50 trades

Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2026-01-02+875,000→ 875,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2026-01-02+240,000→ 240,000 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-08-20$14.09/sh−37,656→ 1,247,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-08-19$14.03/sh−12,344→ 1,285,103 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2025-01-02+767,600→ 767,600 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2025-01-02+261,900→ 261,900 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-17$11.67/sh−50,000→ 1,098,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-17$11.67/sh−50,000→ 1,297,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-10$13.16/sh−50,000→ 1,148,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-10$13.17/sh−50,000→ 1,246,494 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2024-12-06−13,789→ 20,684 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-06$1.44/sh+13,789→ 3,421,636 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2024-12-06−11,876→ 338,124 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-06$8.42/sh+11,876→ 4,327,189 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2024-12-06−11,876→ 1,088,124 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-06$8.42/sh+11,876→ 3,433,512 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-19$13.95/sh−50,000→ 1,347,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-19$13.95/sh−50,000→ 1,198,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-12$16.76/sh−45,045→ 1,301,449 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-12$17.64/sh−4,876→ 1,248,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-12$16.76/sh−45,124→ 1,253,375 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-12$17.64/sh−4,955→ 1,296,494 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-15$14.88/sh−50,000→ 1,298,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-15$15.25/sh−1,450→ 1,397,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-15$14.86/sh−48,550→ 1,398,897 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-08$13.83/sh−50,000→ 1,346,494 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-10-08$13.83/sh−50,000→ 1,348,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-09-17$12.93/sh−50,000→ 1,398,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-09-17$12.93/sh−50,000→ 1,447,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-09-10$11.50/sh−50,000→ 1,396,494 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-09-10$11.50/sh−50,000→ 1,448,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$15.61/sh−11,756→ 1,499,747 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$16.25/sh−2,261→ 1,498,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$16.26/sh−2,300→ 1,497,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$14.76/sh−36,216→ 1,512,283 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$14.76/sh−35,944→ 1,511,503 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-20$15.62/sh−11,523→ 1,500,760 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-13$12.77/sh−35,363→ 1,548,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-13$11.77/sh−14,637→ 1,583,862 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-13$12.76/sh−35,401→ 1,446,494 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-13$11.78/sh−14,599→ 1,481,895 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-07-16$11.40/sh−50,000→ 1,598,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-07-16$11.40/sh−50,000→ 1,547,447 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-07-09$9.62/sh−50,000→ 1,496,494 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-07-09$9.62/sh−50,000→ 1,648,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-12$9.14/sh−48,028→ 1,698,499 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-12$9.15/sh−47,834→ 1,546,494 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-11$9.00/sh−1,972→ 1,746,527 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-06-11$9.00/sh−2,166→ 1,594,328 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-05-16$9.06/sh−44,746→ 1,597,447 total

Companies

ARS Pharmaceuticals, Inc.
CHIEF MEDICAL OFFICER, 10% Owner
$SPRY

Recent Filings

Address

C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov